Industry network BioMelbourne Network connects biotechnology, medical technology, pharmaceuticals and health innovation firms in Victoria, presenting a centralized audience for cross-sector partnership pitches, pilot programs, and commercial collaboration opportunities.

Growth readiness With a mission to enable development and commercialisation of new drugs, devices, diagnostics and digital health technologies, there is a clear demand for funding, strategic partnerships, and go-to-market support from ecosystem players and service providers.

Member activity Active engagement through events such as Connecting Women Lunch, AGM networking, and leadership programs signals ongoing opportunities for sponsorship, keynote slots, and targeted outreach to decision makers within Almac Group and other members.

Strategic alliances Recent collaborations between member companies and academic or research institutions (for example with The University of Melbourne) highlight a need for joint grant applications, contract research, and co-development engagements that vendors can facilitate.

Scale sensitivity Operating with 11-50 employees and revenue in the mid-range, BioMelbourne Network members may be seeking scalable solutions in regulatory affairs, contract manufacturing, digital health platforms, and cost-efficient CROs to support rapid growth and internationalisation.